About Us
Building advanced manufacturing technology for life.
Spun out from Harvard in 2022, AcousticaBio is a venture-backed, NIH-funded preclinical biotechnology company focused on solving the greatest challenges in the delivery of novel therapeutics by using our proprietary fluid processing technology. With strong in-vitro and in-vivo safety and efficacy data, we've built collaborations with leading global biopharmaceutical companies.
.png)
TEAM
The future of life sciences requires innovative experts.
We're building a better future.
Professor Jennifer Lewis
SCIENTIFIC CO-FOUNDER
Anjali Kumar, Ph.D.
CBO & STRATEGIC ADVISOR
Amelia Burns
RESEARCH ASSOCIATE
James Lloyd
BUSINESS OPERATIONS
Emma Buerger
BUSINESS DEVELOPMENT INTERN
Filippo Campanelli
HARDWARE ENGINEERING INTERN
ADVISORS
Professor Mark Skylar-Scott
SCIENTIFIC ADVISOR
Marcello Damiani, MBA
STRATEGIC ADVISOR





















